On the afternoon of March 14,
themed "Gathering industry-academia-research innovation momentum
to build a high-quality development system",
the 4th Shenzhen Enterprise Innovation Promotion Conference and
the 2023 Annual Meeting of the Shenzhen Federation of Industry
was held in grand fashion at the Wuzhou Hotel in Shenzhen.
The conference solemnly announced and honored multiple awards, including the 22nd Shenzhen Enterprise Innovation Record and the 2023 Greater Bay Area Enterprise Innovation List. Beike Biotech made the cut on the strength of its capabilities, sweeping four honors at once —
Beike Biotech
received the "22nd Shenzhen Enterprise Innovation Record — Independent Innovation Benchmark Enterprise"
received the "2023 Guangdong-Hong Kong-Macao Greater Bay Area Enterprise Innovation List — High-Growth Innovation List"
Beike Biotech founder and Chairman Dr. Hu Junyuan
was selected for the "2023 Guangdong-Hong Kong-Macao Greater Bay Area Enterprise Innovation List — Outstanding Innovator List"
was selected for the "2023 Guangdong-Hong Kong-Macao Greater Bay Area Enterprise Innovation List — Outstanding Contributor in Innovation"
01. Shenzhen Enterprise Innovation Record showcases the vitality of technological innovation
The "Shenzhen Enterprise Innovation Record" review and announcement program was launched in 2002 and has now run for 22 editions. The 22nd "Shenzhen Enterprise Innovation Record" reviewed and approved 209 projects from 157 enterprises, covering 28 industries including communications equipment, software, medical devices, pharmaceutical manufacturing, and general equipment manufacturing.
Earlier, in the previously announced 22nd "Shenzhen Enterprise Innovation Record", Beike Biotech's submitted project "Key Technology Innovation and Clinical Application Research of Allogeneic Mesenchymal Stem Cells in the Treatment of Refractory Lupus Erythematosus" was successfully selected for the "Shenzhen Enterprise Innovation Record" and won the "Product R&D Innovation Project Award". Of the 209 projects approved this edition, only 27 received the 22nd "Shenzhen Enterprise Innovation Record" Product R&D Innovation Project Award.
02. The 2023 Greater Bay Area Enterprise Innovation List
The 2023 Guangdong-Hong Kong-Macao Greater Bay Area Enterprise Innovation List was jointly organized by the Shenzhen Federation of Industry, the Bay Area New Economy Research Institute of Guangdong Province, the Shenzhen Association for Science and Technology, Shenzhen Lihe Hi-Tech Co., Ltd., the Shenzhen Economic Daily, the Shenzhen Innovation and Development Research Institute, and other organizations. The selected enterprises possess strong overall capabilities — including national-level manufacturing single-product champions whose market shares rank first in China and top three globally, as well as specialized, refined, distinctive, and innovative "little giant" enterprises with outstanding innovation capability. Overall, the selected enterprises all attach great importance to independent innovation and have strong core competitiveness; they have achieved outstanding innovation results in strategic emerging industries; and they hold leading positions in their industries, driving integrated development across industry chains. Those selected for the "Outstanding Innovators List" are entrepreneurs and technology leaders whose innovation achievements have led their enterprises to outstanding success.
Receiving these honors is high recognition of Beike Biotech's growth value, scientific research strength, and innovation achievements, and a full affirmation of its strategy of "leading high-quality enterprise development through innovation". This is both a recognition and a responsibility that drives the company onward. Innovation is the powerful momentum behind high-quality enterprise development. In the future, Beike Biotech will continue to refine its work in the cell field, regard the translation of innovative scientific and technological achievements as an important driver of corporate development, actively explore new application areas of life science innovation, provide customers with more valuable, more cutting-edge, more advanced products, and drive the high-quality development of China's life sciences industry.
